Jim Simons Trans Medics Group, Inc. Transaction History

Renaissance Technologies LLC

$70.6 Billion
Q3 2025

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 145,199 shares of TMDX stock, worth $16.7 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

145,199

Holding current value

$16.7 Million

% of portfolio

0.02%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$103.61 - $132.04 $15 Million - $19.2 Million	145,199 New	145,199 $16.3 Million
Q3 2024 Nov 13, 2024	SELL	$135.68 - $176.11 $2.73 Million - $3.54 Million	-20,100 Reduced 15.24%	111,799 $17.6 Million
Q2 2024 Aug 09, 2024	BUY	$72.62 - $150.62 $4.95 Million - $10.3 Million	68,100 Added 106.74%	131,899 $19.9 Million
Q1 2024 May 13, 2024	BUY	$70.86 - $89.93 $3.69 Million - $4.69 Million	52,100 Added 445.34%	63,799 $4.72 Million
Q4 2023 Feb 13, 2024	SELL	$36.74 - $81.08 $499,664 - $1.1 Million	-13,600 Reduced 53.76%	11,699 $923,000
Q3 2023 Nov 14, 2023	SELL	$53.47 - $96.07 $2.54 Million - $4.56 Million	-47,500 Reduced 65.25%	25,299 $1.39 Million
Q2 2023 Aug 11, 2023	BUY	$66.23 - $88.73 $635,808 - $851,808	9,600 Added 15.19%	72,799 $6.11 Million
Q1 2023 May 12, 2023	BUY	$53.63 - $82.33 $3.39 Million - $5.2 Million	63,199 New	63,199 $4.79 Million
Q3 2022 Nov 14, 2022	BUY	$31.56 - $55.75 $3.25 Million - $5.74 Million	102,999 New	102,999 $4.3 Million

Others Institutions Holding TMDX

# of Institutions

437

Shares Held

30.4M

Call Options Held

1.03M

Put Options Held

934K

View Full List

About TransMedics Group, Inc.

Ticker TMDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 31,831,400
Market Cap $3.66B
Description
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...

More about TMDX

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account